Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 1681 2791 431
Operating income (EBITDA)161231289325364411
Operating profit (EBIT)120185-272303374
Pre-Tax Profit (EBT)105170213259294351
Net income72,5139177181205250
P/E ratio34,239,031,231,227,522,3
EPS ( € )0,791,511,921,992,262,79
Dividend per Share ( € )0,220,33-0,450,670,55
Yield0,81%0,56%-0,72%1,09%0,88%
Reference price ( € )26.883358.959.9762.1762.1762.17
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,459,04,35--
Finance----68,7-
Operating income (EBITDA)161231289325364411
Leverage
(Debt/EBITDA)
0,54x0,37x0,20x0,01x--
Capital Expenditure47,153,079,7104107122
Book Value Per Share (BVPS)5,78 €6,96 €8,22 €10,1 €12,0 €14,3 €
Cash Flow per Share1,21 €1,52 €-2,48 €2,83 €3,02 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 5 731 M€ -
Entreprise Value (EV) 5 735 M€ 5 662 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 31,2x 27,5x
Capitalization / Revenue 4,91x 4,48x
EV / Revenue 4,91x 4,43x
EV / EBITDA 17,7x 15,6x
Yield (DPS / Price) 0,72% 1,09%
Price to book (Price / BVPS) 6,15x 5,18x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 23,3% 23,7%
operating Leverage (Delta EBIT / Delta Sales) - 1,17x
Net Margin (Net Profit / Revenue) 15,5% 16,0%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 20,8% 19,7%
Rate of Dividend 22,4% 29,9%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   8,91% 8,40%
Cash Flow / Sales 19,5% 20,4%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,01x -0,19x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend